For treatment of polycythemia vera, FDA approves Jakafi, a targeted therapy
The FDA approved Jakafi, a pill, for use in treating polycythemia vera. The drug, a targeted kinase inhibitor manufactured by Incyte, offers a needed option for some people affected by this serious blood disorder, a type of myeloproliferative disease.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063